Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole-boosted fosamprenavir pharmacokinetic evaluation
NL-OMON32580Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of posaconazole and fosamprenavir in mycoses, oral candidiasis, Candida esophagitis and 1 more (6 arms), sponsored by Radboud University Medical Center. Primary endpoints: Effect of posaconazole on fosamprenavir pharmacokinetics and Effect of fosamprenavir on posaconazole pharmacokinetics. Started Mar 2009; status: active, not recruiting.
02
Drugs
posaconazolefosamprenavir
03
Conditions
mycosesoral candidiasisCandida esophagitishuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON32580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32580.